218 related articles for article (PubMed ID: 27729425)
1. Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes.
Velho G; El Boustany R; Lefèvre G; Mohammedi K; Fumeron F; Potier L; Bankir L; Bouby N; Hadjadj S; Marre M; Roussel R
Diabetes Care; 2016 Dec; 39(12):2288-2295. PubMed ID: 27729425
[TBL] [Abstract][Full Text] [Related]
2. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Velho G; Ragot S; El Boustany R; Saulnier PJ; Fraty M; Mohammedi K; Fumeron F; Potier L; Marre M; Hadjadj S; Roussel R
Cardiovasc Diabetol; 2018 Aug; 17(1):110. PubMed ID: 30071874
[TBL] [Abstract][Full Text] [Related]
3. Lower-extremity amputation as a marker for renal and cardiovascular events and mortality in patients with long standing type 1 diabetes.
Mohammedi K; Potier L; Belhatem N; Matallah N; Hadjadj S; Roussel R; Marre M; Velho G
Cardiovasc Diabetol; 2016 Jan; 15():5. PubMed ID: 26743116
[TBL] [Abstract][Full Text] [Related]
4. Plasma copeptin and renal outcomes in patients with type 2 diabetes and albuminuria.
Velho G; Bouby N; Hadjadj S; Matallah N; Mohammedi K; Fumeron F; Potier L; Bellili-Munoz N; Taveau C; Alhenc-Gelas F; Bankir L; Marre M; Roussel R
Diabetes Care; 2013 Nov; 36(11):3639-45. PubMed ID: 23863910
[TBL] [Abstract][Full Text] [Related]
5. Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.
Potier L; Roussel R; Marre M; Bjornstad P; Cherney DZ; El Boustany R; Fumeron F; Venteclef N; Gautier JF; Hadjadj S; Mohammedi K; Velho G
Diabetes Care; 2019 Dec; 42(12):2290-2297. PubMed ID: 31582427
[TBL] [Abstract][Full Text] [Related]
6. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.
Sanchez M; Roussel R; Hadjadj S; Moutairou A; Marre M; Velho G; Mohammedi K
Diabetologia; 2018 Apr; 61(4):977-984. PubMed ID: 29185011
[TBL] [Abstract][Full Text] [Related]
8. Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy.
Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
Diabetes Care; 2010 Jul; 33(7):1567-72. PubMed ID: 20357380
[TBL] [Abstract][Full Text] [Related]
9. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
Pilemann-Lyberg S; Hansen TW; Tofte N; Winther SA; Theilade S; Ahluwalia TS; Rossing P
Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
[TBL] [Abstract][Full Text] [Related]
10. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
11. Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes.
Bjornstad P; Maahs DM; Jensen T; Lanaspa MA; Johnson RJ; Rewers M; Snell-Bergeon JK
J Diabetes Complications; 2016 Aug; 30(6):1093-6. PubMed ID: 27141815
[TBL] [Abstract][Full Text] [Related]
12. Plasma extracellular superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Mohammedi K; Bellili-Muñoz N; Marklund SL; Driss F; Le Nagard H; Patente TA; Fumeron F; Roussel R; Hadjadj S; Marre M; Velho G
Cardiovasc Diabetol; 2015 Jan; 14():845. PubMed ID: 25855220
[TBL] [Abstract][Full Text] [Related]
13. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
Theilade S; Hansen TW; Rossing P
Am J Hypertens; 2014 Sep; 27(9):1152-9. PubMed ID: 24627444
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
15. Copeptin predicts coronary artery disease cardiovascular and total mortality.
Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
[TBL] [Abstract][Full Text] [Related]
17. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
[TBL] [Abstract][Full Text] [Related]
18. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
[TBL] [Abstract][Full Text] [Related]
19. Copeptin, a surrogate marker for arginine vasopressin, is associated with disease severity and progression in IgA nephropathy patients.
Zittema D; van den Brand JA; Bakker SJ; Wetzels JF; Gansevoort RT
Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i146-i153. PubMed ID: 28057871
[TBL] [Abstract][Full Text] [Related]
20. Relationship of mildly increased albuminuria and coronary artery revascularization outcomes in patients with diabetes.
Siddique A; Murphy TP; Naeem SS; Siddiqui EU; Pencina KM; McEnteggart GE; Sellke FW; Dworkin LD
Catheter Cardiovasc Interv; 2019 Mar; 93(4):E217-E224. PubMed ID: 30467952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
